Core Insights - Intuitive Surgical, Inc. (ISRG) is a leading company in the medical instruments & supplies industry, specializing in products that enhance minimally invasive care, with a market cap of $205.8 billion [1][2] - The company is recognized for its robotic-assisted surgery systems, particularly the da Vinci system, which is supported by strong brand reputation and continuous investment in R&D [2] Financial Performance - ISRG reported Q3 revenue of $2.51 billion, exceeding analyst expectations by 3.9%, and an adjusted EPS of $2.40, surpassing estimates of $1.99 [5] - The stock experienced a 13.9% surge following the Q3 results announcement [5] - Year-to-date, ISRG shares have risen 10%, while over the past 52 weeks, they have climbed 5.9%, underperforming the Nasdaq Composite's YTD gains of 20.2% [4] Stock Performance - Despite a recent slip of 6.8% from its 52-week high of $616, ISRG stock gained 21.1% over the past three months, outperforming the Nasdaq Composite's 7.8% gains [3][4] - The stock has been trading above its 50-day and 200-day moving averages since late October, indicating a bullish trend [4] Analyst Sentiment - Wall Street analysts maintain a consensus "Moderate Buy" rating for ISRG, with a mean price target of $610.28, suggesting a potential upside of 6.3% from current levels [6]